Crossmark

Association of cardiovascular-kidney-metabolic syndrome stages with MASLD prevalence and liver fibrosis severity: evidence from traditional and machine learning approaches

Crossref DOI link: https://doi.org/10.1186/s40001-026-04037-0

Published Online: 2026-02-14

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zheng, Yangyang

Li, Ting

Guo, Shiqi

Song, Jinghai https://orcid.org/0000-0003-1798-3229
Funding

Funding for this research was provided by:

National High Level Hospital Clinical Research Funding (Grant no. BJ-2023-083)
License Information

Text and Data Mining valid from 2026-02-14

Version of Record valid from 2026-03-23
More Information

Article History

Received: 11 September 2025

Accepted: 4 February 2026

First Online: 14 February 2026

Declarations

:

: This study used anonymous data from the National Health and Nutrition Examination Survey and complied with the ethical guidelines and regulations of the Declaration of Helsinki. The study was approved by the National Center for Health Statistics Ethics Review Board, and all participants provided written informed consent before the study.

: Not Applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below